On the other hand, elevated expression levels of AC002094.4, LINC01094, AC009812.3, AC095057.3, and AP001189.3 in the high-risk group suggest these molecules may contribute to poorer clinical outcomes, marking them as potential risk factors in GC progression. The gene discussed is LINC01094; the disease is gastric cancer.